Search results
Oct 24, 2018 · The Perceval valve (LivaNova, London, United Kingdom) is a collapsible, sutureless bioprosthetic aortic valve. This novel design is well suited for minimally invasive approaches and has particular advantages for patients with small, calcified annuli. The implantation technique is unique, and echocardiographic assessments of valve cage shape ...
- Vishnu Vasanthan, William Kent, Alexander Gregory, Andrew Maitland, Charles Cutrara, Denis Bouchard,...
- 2019
Perceval is a pericardial surgical heart valve with a sutureless and collapsible design that simplifies the implantation and reduces trauma and complications. It also allows for valve-in-valve procedures and has clear landmarks for transcatheter valve placement.
Jan 5, 2022 · The Perceval valve is a supportive option for high-risk patients and for those at risk of patient–prosthesis mismatch. Sutureless perceval aortic valve vs. conventional stented bioprostheses: meta-analysis of postoperative and midterm results in isolated aortic valve replacement.
- 10.3389/fcvm.2021.789392
- 2021
- Front Cardiovasc Med. 2021; 8: 789392.
Perceval is a bioprosthetic valve designed to replace a diseased native or a malfunctioning prosthetic aortic valve via open heart surgery, with the unique characteristic of allowing...
- 585KB
- 22
Aug 27, 2020 · Perceval Sutureless Aortic Valve Implantation: Midterm Outcomes. Background. Because our center participated in the first-in-human trial with Perceval (LivaNova, Sallugia, Italy) in 2007, this series represents the longest available clinical follow-up (11 years) with sutureless technology in aortic valve replacement. Methods.
- Delphine Szecel, Roxanne Eurlings, Filip Rega, Peter Verbrugghe, Bart Meuris
- 2021
Apr 11, 2023 · Perceval Valve AVR achieves 80% freedom from mortality at 5 years with low valve gradients and minimal morbidity. Perceval Valve Aortic Valve Replacement has acceptable mid-term mortality, durability and haemodynamic outcomes.
Feb 16, 2018 · Background. Aortic stenosis is the most common valvular disease and has a dismal prognosis without surgical treatment. The aim of this meta‐analysis was to quantitatively assess the comparative effectiveness of the Perceval (LivaNova) valve versus conventional aortic bioprostheses.
